Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
0.4626
+0.0018 (0.39%)
At close: May 26, 2026, 4:00 PM EDT
0.4620
-0.0006 (-0.13%)
After-hours: May 26, 2026, 7:41 PM EDT

Cytosorbents Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2940506068182
Market Cap Growth
-46.68%-19.54%-17.13%-10.98%-62.87%-47.12%
Enterprise Value
53.4762.4773.0661.5263.63143.29
Last Close Price
0.460.640.911.111.554.19
PS Ratio
0.781.081.401.941.954.22
PB Ratio
13.236.804.492.561.912.91
P/TBV Ratio
13.476.744.462.111.912.90
EV/Sales Ratio
1.441.692.051.981.833.32
Debt / Equity Ratio
10.064.842.380.660.510.21
Net Debt / Equity Ratio
11.153.872.130.18-0.11-0.61
Net Debt / EBITDA Ratio
-1.94-1.74-1.60-0.140.131.77
Net Debt / FCF Ratio
-2.39-1.82-1.60-0.190.112.17
Asset Turnover
0.450.810.710.540.450.48
Inventory Turnover
2.212.643.512.673.392.97
Quick Ratio
0.731.421.081.442.864.14
Current Ratio
1.092.132.201.813.484.70
Return on Equity (ROE)
-340.77%-96.39%-119.80%-99.38%-67.00%-34.64%
Return on Assets (ROA)
-31.37%-30.72%-30.32%-53.51%-39.94%-24.61%
Return on Invested Capital (ROIC)
-47.96%-44.30%-48.76%-105.11%-109.45%-133.49%
Return on Capital Employed (ROCE)
-47.35%-40.96%-43.03%-69.12%-48.74%-29.23%
Buyback Yield / Dilution
-12.01%-14.32%-21.90%-2.49%-0.49%-11.70%
Total Shareholder Return
-12.01%-14.32%-21.90%-2.49%-0.49%-11.70%
Updated May 13, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q